Condition: Mature B-Cell Neoplasm · Sponsor: Oncology Institute of Southern Switzerland
The study aims at assessing whether cell free DNA genotyping can improve the accuracy of early prediction of cure in mature B-cell tumor patients and whether it represents an accessible source of tumor DNA for the sensitive identification of genetic biomarkers that refine the diagnostic workup, stratify prognosis and identify the emergence of drug-resistance mutations during treatment.
This description comes directly from the study's public registry record.
Davide Rossi, MD, PhD · +41 091 811 8540 · davide.rossi@eoc.ch
Always discuss trial participation with your own doctor first.
| Institute of Oncology Research | Bellinzona, Canton Ticino, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03280394